Clarity Pharmaceuticals Ltd (ASX:CU6 – Get Free Report) insider Colin Biggin acquired 905,625 shares of Clarity Pharmaceuticals stock in a transaction on Wednesday, August 7th. The shares were purchased at an average cost of A$0.67 ($0.44) per share, with a total value of A$604,957.50 ($397,998.36).
Colin Biggin also recently made the following trade(s):
- On Thursday, August 1st, Colin Biggin acquired 542,835 shares of Clarity Pharmaceuticals stock. The shares were acquired at an average price of A$0.67 ($0.44) per share, with a total value of A$363,156.62 ($238,918.83).
Clarity Pharmaceuticals Stock Performance
Clarity Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Clarity Pharmaceuticals
- What Does Downgrade Mean in Investing?
- Brinker International’s Price Dip is an Appetizing Entry Point
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Stocks That Could Beat the September Blues
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Clarity Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarity Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.